...
首页> 外文期刊>Annals of Oncology >Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer
【24h】

Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer

机译:Genexol-PM的多中心II期临床试验,这是一种新型的无Cremophor的紫杉醇聚合物胶束与紫杉醇联合顺铂治疗晚期非小细胞肺癌患者

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Genexol-PM is a novel Cremophor EL (CrEL)-free polymeric micelle formulation of paclitaxel (Taxol). This multicenter phase II study was designed to evaluate the efficacy and safety of the combination of Genexol-PM and cisplatin for the treatment of advanced non-small-cell lung cancer (NSCLC).
机译:背景:Genexol-PM是一种新的不含紫杉醇(Taxol)的不含Cremophor EL(CrEL)的聚合物胶束制剂。这项多中心II期研究旨在评估Genexol-PM和顺铂联合治疗晚期非小细胞肺癌(NSCLC)的有效性和安全性。

著录项

  • 来源
    《Annals of Oncology》 |2007年第12期|2009-2014|共6页
  • 作者单位

    Department of Internal Medicine Seoul National University Hospital Seoul;

    Cancer Research Institute Seoul National University College of Medicine Seoul;

    Department of Internal Medicine Kyung Hee University Hospital Seoul;

    Department of Internal Medicine St Vincent's Hospital Suwon;

    Department of Internal Medicine Asan Medical Center Seoul;

    Department of Internal Medicine Korea University Anam Hospital Seoul;

    Department of Internal Medicine Korea University Guro Hospital Seoul;

    Department of Medicine Samsung Medical Center Seoul;

    Samyang Corporation Seoul Korea;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号